9.15 USD
↘ 0.34 (3.55%)LIVE (AS OF 09:37 AM EDT)
Kyverna Therapeutics, Inc. Common Stock
KYTXNASDAQ • USD
Market: OPEN
Open?$9.63
High?$10.07
Low?$9.21
Prev. Close?$9.49
Volume?90.4K
Avg. Volume?1.1M
VWAP?$9.41
Rel. Volume?0.08x
Bid / Ask
Bid?$8.08 × 100
Ask?$11.06 × 100
Spread?$2.98
Midpoint?$9.57
Valuation & Ratios
Market Cap?576.9M
Shares Out?60.8M
Float?35.7M
Float %?59.1%
P/E Ratio?N/A
P/B Ratio?2.95
EPS?-$2.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
Themes
Employees
129
Market Cap
576.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-02-08
Address
5980 HORTON STREET
EMERYVILLE, CA 94608
Phone: (510) 626-8331
EMERYVILLE, CA 94608
Phone: (510) 626-8331
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.15Strong
Quick Ratio?8.15Strong
Cash Ratio?1.08Strong
Debt/Equity?0.13Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?2.95CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.5CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-80.0%WEAK▾
ROA?-60.9%WEAK▾
Cash Flow & Enterprise
FCF?$-150399000
Enterprise Value?$569.8M
Fundamentals ratios updated end of day